Welcome to the Divis Labs Stock Liveblog, your real-time source for the latest updates and comprehensive analysis on a ...

Stay up-to-date with the Divis Labs Stock Liveblog, your trusted source for real-time updates and thorough analysis of a ...

Vinay Rajani of HDFC Securities says Divis Labs share price has broken out from the box pattern on the daily chart with the primary trend of the stock staying bullish ...

Divis Laboratories is reporting earnings from the most recent quarter on August 8. Wall Street analysts predict earnings per share of INR 11.98. Follow Divis Laboratories stock price in real-time here ...

Divis Laboratories Ltd is quoting at Rs 6125.5, down 1.77% on the day as on 13:19 IST on the NSE. The stock jumped 2.08% in last one year as compared to a 9.4% rally in NIFTY and a 0.15% fall in the ...

Earnings call Divi's Laboratories posted a 25.4% YoY revenue growth for Q3 FY25, with PAT rising 64.5% YoY. Custom synthesis continues to drive growth, while backward integration via the new Kakinada ...

Divis Laboratories shares gained 2.05% to trade at Rs 6,237.50 in Friday's session. At 10:27 am, the stock showed positive movement. Divis Laboratories is included as one of the stocks in the ...

Divi’s Laboratories’ (Divi’s) Q2FY26 result was in line with our expectations on all fronts. Constant currency growth slowed down to ~10.8% vs. 15% QoQ and 18% in FY25. Q2 growth was largely led by ...

Divi's Laboratories has attracted bullish sentiment from leading brokerage houses. The company’s strong fundamentals, robust R&D capabilities, and leadership position in Active Pharmaceutical ...

Divis Laboratories organised a road safety rally in Bheemunipatnam, promoting safe driving and traffic rule adherence among participants.

Earnings call Divi’s Laboratories reported Q2 FY25 consolidated revenue of ₹2,444 crore, up 22.5% YoY and 11.2% QoQ. Profit after tax rose to ₹510 crore, up 46.6% YoY. Custom synthesis now contributes ...